Caribou Biosciences, Inc.
CRBU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -17.6% | 13.3% | 13.3% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | 71.3% | 100% | 100% | -1,337.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,224.6% | -1,284.6% | -1,774.2% | -1,785.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,253.3% | -2,028.4% | -1,699.6% | -1,708.7% |
| EPS Diluted | -0.3 | -0.58 | -0.43 | -0.39 |
| % Growth | 48.3% | -34.9% | -10.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |